Evogene (EVGN) Current Assets (2016 - 2025)

Evogene (EVGN) has disclosed Current Assets for 9 consecutive years, with $15.6 million as the latest value for Q4 2025.

  • Quarterly Current Assets fell 27.6% to $15.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.6 million through Dec 2025, down 27.6% year-over-year, with the annual reading at $15.6 million for FY2025, 27.6% down from the prior year.
  • Current Assets hit $15.6 million in Q4 2025 for Evogene, down from $21.6 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $56.9 million in Q4 2021 to a low of $15.6 million in Q4 2025.
  • Historically, Current Assets has averaged $33.3 million across 5 years, with a median of $34.5 million in 2023.
  • Biggest five-year swings in Current Assets: grew 9.78% in 2021 and later crashed 37.37% in 2024.
  • Year by year, Current Assets stood at $56.9 million in 2021, then crashed by 33.64% to $37.8 million in 2022, then fell by 8.69% to $34.5 million in 2023, then crashed by 37.37% to $21.6 million in 2024, then fell by 27.6% to $15.6 million in 2025.
  • Business Quant data shows Current Assets for EVGN at $15.6 million in Q4 2025, $21.6 million in Q4 2024, and $34.5 million in Q4 2023.